243 results
Page 4 of 13
PRE 14A
z1prt4q6q mx2u0x
10 Aug 20
Preliminary proxy
12:00am
8-K
EX-99.1
8a0lbrib9adkvbmxp4f7
31 Jul 20
Regulation FD Disclosure
4:05pm
10-K
EX-10.2
bee xqwqwyp6
29 Jun 20
Annual report
4:02pm
10-K
b66x6xhxi8df28
29 Jun 20
Annual report
4:02pm
8-K
EX-99.1
lio11owwxzkq
29 Jun 20
Acasti Pharma Provides Fiscal 2020 Year-End Business Update
12:50pm
S-3
EX-1.2
vb46yc mt
29 Jun 20
Shelf registration
12:00am
8-K
EX-99.1
m8xxmbvgj
19 Jun 20
Acasti Pharma Receives FDA Response to TRILOGY 1 Briefing Package
9:09am
8-K
EX-99.1
33wtac5t3kiidr
30 Apr 20
Acasti Pharma Announces Submission of TRILOGY 1 Briefing Package to FDA
4:22pm
8-K
EX-99.1
07hs2rwvi1ht32cd
20 Apr 20
Acasti Pharma Awarded Notice of Allowance for Second Composition of Matter Patent in Canada
4:05pm
8-K
EX-99.1
mpha8
1 Apr 20
Acasti Pharma Submits FDA Meeting Request on Schedule, and FDA Meeting Expected in the Second Half of June
5:12pm
6-K
EX-99.1
q56lu4
11 Mar 20
Acasti Pharma Awarded Notice of Allowance for Additional Composition of Matter and Method of Use Patents in the United States and Mexico
8:00am
6-K
EX-99.1
dukqn rl39h09fl3
28 Feb 20
Acasti Receives NASDAQ Notification Regarding Minimum Bid Requirements
5:00pm
6-K
EX-99.1
rbjr59m
14 Feb 20
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2020
8:00am
6-K
EX-99.3
u0fq n73kb98o
14 Feb 20
Current report (foreign)
8:00am
6-K
EX-99.4
6oqhwumak 4a92k6un
14 Feb 20
Current report (foreign)
8:00am
6-K
EX-99.1
jnkzkjiqtf8x p3
13 Feb 20
Acasti Pharma Schedules Third Quarter Fiscal 2020 and Business Update Conference Call
9:00am
6-K
EX-99.1
5eae r2nuvzpfcb4m7
10 Feb 20
Acasti Pharma Provides Update on TRILOGY 1 and TRILOGY 2 Phase 3 Trials of CaPre
7:00am
6-K
EX-99.1
dz74nv9h
13 Jan 20
Acasti Pharma Reports Topline Results for TRILOGY 1 Phase 3 Trial of CaPre
6:21am
6-K
EX-99.1
urq qathrsx54f0aop
23 Dec 19
Acasti Pharma Provides Update on Timing of Topline Results for TRILOGY 1 Phase 3 Trial of CaPre
8:43pm
6-K
EX-99.1
bdiw8l19
26 Nov 19
Acasti Pharma Reports Last Patient Visit in TRILOGY 1 Phase 3 Trial of CaPre for the Treatment of Severe Hypertriglyceridemia
7:58am